Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 tri... by Shi, Tingyan, MD, Zhu, Jianqing, Prof, Feng, Yanling, MD, Tu, Dongsheng, Prof, Zhang, Yuqin, MD, Zhang, Ping, Prof, Jia, Huixun, MPH, Huang, Xiao, MD, Cai, Yunlang, Prof, Yin, Sheng, Jiang, Rong, Tian, Wenjuan, MD, Gao, Wen, Liu, Jihong, Prof, Yang, Huijuan, Prof, Cheng, Xi, Prof, Zang, Rongyu, Prof

Get full text

Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial by Liu, Xin, MD, Zhang, Xiaowei, MD, Jiang, Shiyu, MD, Mo, Miao, MM, Wang, Qifeng, MD, Wang, Yanli, MM, Zhou, Liangping, MD, Hu, Silong, MD, Yang, Huijuan, Prof, Hou, Yifeng, MD, Chen, Yong, Prof, Lu, Xueguan, MD, Wang, Yu, MD, Zhou, Xiaoyan, Prof, Li, Wentao, MD, Chang, Cai, Prof, Yang, Xiujiang, MD, Chen, Ke, MD, Cao, Jun, MD, Xu, Qinghua, PhD, Sun, Yifeng, MSc, Luo, Jianfeng, MD PhD, Luo, Zhiguo, MD, Hu, Xichun, Prof

Get full text